RxDoctor Payments Data

Virgincita Rodriguez, MD

Family Medicine · Newport, ARNPI 1346552148

Payments from drug & device makers

$909in general payments, 2019–2025

Across 58 payments — averaging $15.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$318
  • AbbVie$181
  • AstraZeneca$64
  • Pfizer$58
  • Otsuka America Pharmaceutical, Inc.$43
  • Boehringer Ingelheim$38
  • plus $207 from 11 others

What the payments were for

  • Food & beverage$909100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$909 in reported general payments places this provider in the 55th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$68,250
Medicare patients
239
Services billed
866

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide70$70,687
OzempicSemaglutide35$40,839
FarxigaDapagliflozin Propanediol46$30,398
JanuviaSitagliptin Phosphate34$23,224
JardianceEmpagliflozin24$20,127
EliquisApixaban32$18,303
Spiriva RespimatTiotropium Bromide21$16,096
QuliptaAtogepant12$15,235
XareltoRivaroxaban17$14,256
Synjardy XrEmpagliflozin/Metformin Hcl16$13,035
MyrbetriqMirabegron11$12,650
Praluent PenAlirocumab15$12,164
Tresiba Flextouch U-100Insulin Degludec22$11,794
Xigduo XrDapaglifloz Propaned/Metformin21$11,520
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$10,858

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat, Synjardy Xr, Combivent Respimat, Synjardy$38$70,794102 claims
AstraZenecaFarxiga, Breztri Aerosphere$64$41,25665 claims
AbbVieQulipta, Linzess$181$23,44227 claims
PfizerEliquis, Prempro$58$20,93444 claims
Johnson & JohnsonXarelto$24$14,25617 claims
GSKAnoro Ellipta, Incruse Ellipta$36$11,61727 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Newport

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →